What is the main business of Citofarm?

The main business activity of Citofarm focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on October 22, 2002.

Where is the headquarters located?

The headquarters is located at: ul. Kinga C. Gillette 11, 94-406 Łódź.

Who is on the management board?

The management board includes: Bożena Szymańska (President of the Management Board) and Katarzyna Nockowska Stańczak (Vice President of the Management Board).

What is the share capital?

The share capital of the company is PLN 1,847,000 (approx. $498,920).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of $2,323,049, representing an increase of 9.6% compared to 2024.

Is the company profitable?

No, the company recorded a net loss of $46,474 in 2025. For comparison, in 2024 the loss was $26,768, meaning the company increased its loss by 73.2%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $1,818,227 in 2025, representing 77% of all operating expenses.

Citofarmsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2002-10-22

Share capital

1 847 000,00 PLN

Registered address

ul. Kinga C. Gillette 11, 94-406 Łódź, Poland

Electronic delivery address

AE:PL-65157-17626-GJSAI-22

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 2.32mMedianUSD 1.76mAverageUSD 4.96m

Net profit

This companyUSD -46.47kMedianUSD 17.49kAverageUSD 77.31k

Operating costs

This companyUSD 2.35mMedianUSD 1.72mAverageUSD 4.80m

Assets

This companyUSD 640.73kMedianUSD 495.60kAverageUSD 1.69m

Industry

Bank accounts

Registered as a VAT taxpayer on 2002-12-02. Active

ING Bank Śląski
10 1050 0086 1000 0023 1595 6504
ING Bank Śląski
65 1050 0086 1000 0023 1942 9375

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Aleksandra Olszacka — Vice President of the Management Board

Bożena Szymańska — President of the Management Board

Katarzyna Nockowska Stańczak — Vice President of the Management Board

Manner of representation

In the case of a multi-member management board, joint action by two members of the management board or by a member of the management board with a commercial proxy is required for the validity of declarations made on behalf of the company. The commercial proxy makes declarations on behalf of the company jointly with a member of the management board or, if joint commercial proxy has been granted, with another commercial proxy.

Ownership

Owner	Shares	Share value	Stake
Apteki Cefarm sp. j.	2,807	$379,119.39	75.9881%
DOZ S.A.	887	$119,800.11	24.0119%

Beneficial owners

Person	Rights
Zbigniew Jacek Molenda (63)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji spółki
Jacek Romuald Szwajcowski (62)	Sprawowanie kontroli nad osobami prawnymi, którym łącznie przysługuje prawo własności więcej niż 25% ogólnej liczby udziałów lub akcji spółki

Competitors

Name	Revenue	Website
Novopharm - Millersp. j.	$2,839,228.36	apteka.zyj-zdrowo.com
Pikadasp. z o.o.	$1,903,088.18	apteka-propharma.pl
Vitasp. z o.o.	$1,873,952.10	vita-wroclaw.pl
Gold Lionsp. z o.o.	$1,669,649.21	goldlion.pl
Grupa Aptekarska Kujałowiczsp. j.	$1,452,484.91	wga.pl
Herbarium Świętego Franciszkasp. z o.o.	$1,397,577.12	herbarium.katowice.pl
Eurekasp. z o.o.	$1,377,733.77	fundacja-eureka.edu.pl
MaglowS.A.	$1,356,219.12	maglow.pl
Farmacja Im. O. Klimuszkisp. z o.o.	$1,289,548.20	zyj-zdrowo.com
Awicennasp. j.	—	a-medyczny.pl

Change history

Date	Event
2018-03-06	Share capital change (1,845,000.00 PLN → 1,847,000.00 PLN)
2015-11-10	Address change (Wyspiańskiego 4, 95-200, Pabianice → Ul. Kinga C. Gillette 11, 94-406, Łódź)
2015-07-24	PKD change (Removed: 10.86.Z, 10.89.Z, 21.10.Z, 49.41.Z, 63.11.Z, 63.12.Z, 64.20.Z, 68.10.Z, 68.20.Z, 70.10.Z, 70.22.Z, 73.20.Z, 77.11.Z, 77.12.Z, 77.33.Z, 77.39.Z, 78.10.Z, 78.30.Z, 82.30.Z, 82.99.Z, 85.59.B)
2010-03-29	PKD change (Removed: 15.98.Z, 22.11.Z, 22.12.Z, 22.13.Z, 22.14.Z, 22.15.Z, 22.21.Z, 22.22.Z, 22.23.Z, 22.24.Z, 22.25.Z, 22.31.Z, 22.32.Z, 22.33.Z, 30.01.Z, 30.02.Z, 40.10.A, 40.10.B, 40.11.Z, 40.12.Z, 40.13.Z, 40.21.Z, 40.22.Z, 45.11.Z, 45.12.Z, 45.21.A, 45.21.G, 45.22.Z, 45.24.B, 45.25.A, 45.25.B, 45.25.C, 45.25.D, 45.25.E, 45.31.A, 45.31.D, 45.32.Z, 45.33.A, 45.33.B, 45.33.C, 45.34.Z, 45.41.Z, 45.42.Z, 45.43.A, 45.43.B, 45.44.A, 45.44.B, 45.45.Z, 45.50.Z, 51.19.Z, 52.31.Z, 52.33.Z, 55.10.Z, 55.21.Z, 55.22.Z, 55.23.Z, 55.30.A, 55.30.B, 55.40.Z, 55.51.Z, 55.52.Z, 60.24.A, 60.24.B, 60.24.C, 63.11.C, 63.12.C, 64.12.A, 65.21.Z, 65.23.Z, 70.11.Z, 70.12.Z, 70.20.Z, 70.31.Z, 70.32.Z, 71.10.Z, 71.21.Z, 72.10.Z, 72.21.Z, 72.22.Z, 72.30.Z, 72.40.Z, 72.60.Z, 74.13.Z, 74.14.A, 74.30.Z, 74.40.Z, 74.50.A, 74.60.Z, 74.70.Z, 74.87.A, 74.87.B, 80.42.A, 80.42.B, 85.12.Z, 85.13.Z, 85.14.C, 85.14.E, 85.14.F, 85.31.B, 85.32.A, 85.32.C, 93.02.Z, 93.04.Z, 95.05.Z; Added: 10.86.Z, 10.89.Z, 21.10.Z, 21.20.Z, 47.19.Z, 47.29.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.91.Z, 49.41.Z, 52.10.B, 63.11.Z, 63.12.Z, 64.20.Z, 64.99.Z, 68.10.Z, 68.20.Z, 70.10.Z, 70.22.Z, 73.20.Z, 77.11.Z, 77.12.Z, 77.33.Z, 77.39.Z, 78.10.Z, 78.30.Z, 82.30.Z, 82.99.Z, 85.59.B, 86.90.E)
2008-03-17	Share capital change (345,000.00 PLN → 1,845,000.00 PLN)

FAQ

Last updated: 2026-06-08